Courier Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
1,773
+4
+0.2% +$527 0.01% 376
2026
Q1
$247K Buy
+1,769
New +$248K 0.01% 349
2024
Q2
Sell
-8,965
Closed -$657K 348
2024
Q1
$657K Sell
8,965
-100
-1% -$7.69K 0.05% 217
2023
Q4
$734K Sell
9,065
-165
-2% -$12.8K 0.06% 204
2023
Q3
$692K Sell
9,230
-27
-0.3% -$2.08K 0.06% 207
2023
Q2
$713K Buy
+9,257
New +$738K 0.06% 211
2018
Q3
Sell
-35,563
Closed -$2.52M 297
2018
Q2
$2.52M Sell
35,563
-5,552
-14% -$392K 0.32% 73
2018
Q1
$3.1M Sell
41,115
-796
-2% -$63.3K 0.41% 61
2017
Q4
$3M Sell
41,911
-10,272
-20% -$780K 0.39% 66
2017
Q3
$4.23M Buy
+52,183
New +$3.99M 0.59% 45
2016
Q3
Sell
-4,039
Closed -$337K 280
2016
Q2
$337K Sell
4,039
-731
-15% -$64.9K 0.07% 206
2016
Q1
$438K Buy
4,770
+487
+11% +$43.9K 0.09% 152
2015
Q4
$433K Buy
4,283
+200
+5% +$20.8K 0.09% 152
2015
Q3
$401K Buy
4,083
+19
+0.5% +$2.11K 0.09% 160
2015
Q2
$476K Sell
4,064
-892
-18% -$97.5K 0.1% 148
2015
Q1
$486K Buy
4,956
+1,508
+44% +$153K 0.1% 158
2014
Q4
$325K Buy
3,448
+350
+11% +$36.2K 0.07% 201
2014
Q3
$330K Buy
+3,098
New +$303K 0.07% 201

Other funds holding GILD

Courier Capital's GILD Position: Q2 2026 in Review

Courier Capital increased its Gilead Sciences (GILD) stake by 0.23% in Q2 2026, buying an estimated $527 and bringing the position to 1,773 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #376.

Courier Capital first reported a position in GILD in Q3 2014 and has held it in 18 quarters since. The position peaked at $4.23M in Q3 2017. 1,095 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Courier Capital held 1,773 shares of Gilead Sciences worth $224K as of Q2 2026.
  • Courier Capital bought 4 Gilead Sciences shares in Q2 2026, an estimated $527.
  • Gilead Sciences made up 0.01% of Courier Capital's portfolio in Q2 2026, its #376 holding.
  • Courier Capital first reported a position in Gilead Sciences in Q3 2014 and has held it in 18 quarters since.
  • Courier Capital's Gilead Sciences position peaked at $4.23M in Q3 2017.
  • 1,095 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.